Bridgewater Advisors Inc.

Position in ABBV — AbbVie Inc.

CIK 1600319 NEW YORK, NY

Position in ABBV

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$2,441,411

+$309,357 QoQ

Shares Held

9,702

-1.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

#1,810

of 4,153 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bridgewater Advisors Inc. holds $24,557,436 across 14 Drug Manufacturers - General names. ABBV ranks #4 (9.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	22,989	$5,838,516
2	LLY	ELI LILLY & Co	3,983	$4,777,330
3	MRK	Merck & Co., Inc.	23,905	$3,071,792
4	ABBV	AbbVie Inc. This page	9,702	$2,441,411
5	AMGN	Amgen Inc	5,459	$1,976,813
6	NVS	Novartis AG	10,369	$1,625,029
7	PFE	Pfizer Inc	62,287	$1,499,870
8	AZN	Astrazeneca PLC	4,442	$842,292

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,441,411	9,702	-1.0%	Shares	Sole	2026-08-05
2026-03-31	$2,132,054	9,803	-3.0%	Shares	Sole	2026-05-14
2025-12-31	$2,308,205	10,102	-1.4%	Shares	Sole	2026-01-23
2025-09-30	$2,372,127	10,245	+2.0%	Shares	Sole	2025-11-10
2025-06-30	$1,864,367	10,044	+0.2%	Shares	Sole	2025-08-05
2025-03-31	$2,100,857	10,027	+233.0%	Shares	Sole	2025-05-02
2022-06-30	$461,164	3,011	-6.3%	Shares	Sole	2022-08-05
2022-03-31	$521,183	3,215	+26.6%	Shares	Sole	2022-05-05
2021-12-31	$343,916	2,540	+1.9%	Shares	Sole	2022-02-07
2021-09-30	$268,919	2,493	+4.3%	Shares	Sole	2021-11-02
2021-06-30	$269,322	2,391	—	Shares	Sole	2021-08-06
No filing history on record for this holder in this stock.